Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
Charts & Report
Charts and Graphs
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Divi's Laboratories Ltd.
NSE: DIVISLAB
|
BSE: 532488
|
ISIN: INE361B01024
|
Industry: Pharmaceuticals
|
Expensive Performer
6767.0000
103.50
(
1.55
%)
NSE
Jun 18, 2026
15:31 PM
Near 52W High of ₹7071.50
Volume:
411.9K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Divi's Laboratories Ltd.
05 Aug 2024
6767.00
1.55%
Divi's Laboratories
Hold:
Divi's Laboratories Ltd.
by
ICICI Direct
Target: 4865
Target
ICICI Direct
Number of FII/FPI investors decreased from 868 to 842 in Mar 2026 qtr
More from Divi's Laboratories Ltd.
Recommended
Market closes higher on lower oil prices and foreign fund inflows
Trendlyne Marketwatch |
18 Jun 2026, 04:03PM
India Inc tests the tolerance of consumers for higher prices
The Baseline |
18 Jun 2026, 10:54AM
Custom synthesis business drives growth for Divi’s Laboratories
|
10 Mar 2022